GW&K Investment Management, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1082917 BOSTON, MA

Position in VRTX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$103,816

+$20,760 QoQ

Shares Held

209

+12.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#1,474

of 1,735 holders

Holding Since

Mar 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GW&K Investment Management, LLC holds $876,997,841 across 27 Biotechnology names. VRTX ranks #17 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	1,353,883	$105,968,422
2	JAZZ	Jazz Pharmaceuticals plc	350,667	$84,500,226
3	BBIO	BridgeBio Pharma, Inc.	1,125,131	$83,799,756
4	CYTK	Cytokinetics Inc	916,107	$78,043,155
5	LGND	Ligand Pharmaceuticals Inc	246,883	$78,037,246
6	VCEL	Vericel Corp	1,550,497	$68,981,610
7	INSM	INSMED Inc	629,760	$67,145,010
8	CRNX	Crinetics Pharmaceuticals, Inc.	1,731,140	$64,779,258

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$103,816	209	+12.4%	Shares	Sole	2026-08-12
2026-03-31	$83,056	186	+23.2%	Shares	Sole	2026-05-13
2025-12-31	$68,457	151	+5.6%	Shares	Sole	2026-02-11
2025-09-30	$56,004	143	-11.2%	Shares	Sole	2025-11-12
2025-06-30	$71,677	161	+12.6%	Shares	Sole	2025-08-11
2025-03-31	$69,329	143	+8.3%	Shares	Sole	2025-05-05
2024-12-31	$53,156	132	-0.8%	Shares	Sole	2025-02-05
2024-09-30	$61,855	133	+31.7%	Shares	Sole	2024-11-07
2024-06-30	$47,340	101	+21.7%	Shares	Sole	2024-08-12
2024-03-31	$34,694	83	-13.5%	Shares	Sole	2024-05-08
2023-12-31	$39,061	96	+3.2%	Shares	Sole	2024-02-09
2023-09-30	$32,339	93	+4.5%	Shares	Sole	2023-11-09
2023-06-30	$31,319	89	+196.7%	Shares	Sole	2023-08-09
2022-06-30	$8,453	30	+66.7%	Shares	Sole	2022-08-09
2022-03-31	$4,697	18	—	Shares	Sole	2022-05-09
No filing history on record for this holder in this stock.